MétaCan
Menu
← Back to cohort
Record W7117652343 · doi:10.1016/j.vaccine.2025.128160

Humoral and cellular immunogenicity of sequential heterogeneous bivalent SARS-CoV-2 vaccinations in long-term care and retirement home residents

2025· article· en· W7117652343 on OpenAlexafffundabout
Jessica A. Breznik, Jann C. Ang, Hina Bhakta, Li-Min Liu, Lucas Bilaver, Allison Kennedy, Braeden Cowbrough, Ahmad Rahim, Rumi Clare, Jonathan L. Bramson, Ishac Nazy, Matthew S. Miller, Andrew P. Costa, Dawn M.E. Bowdish

Bibliographic record

VenueVaccine · 2025
Typearticle
Languageen
FieldMedicine
TopicSARS-CoV-2 and COVID-19 Research
Canadian institutionsMcMaster University Medical CentreImpactThrombosis and Atherosclerosis Research InstituteMcMaster UniversitySt. Joseph’s Healthcare Hamilton
FundersCanadian Institutes of Health ResearchMcMaster Institute for Research on Aging, McMaster UniversityPublic Health Agency of Canada
KeywordsBivalent (engine)ImmunogenicityVaccinationImmune systemAntibody responseHumoral immunity

Abstract

fetched live from OpenAlex

Older adults were administered sequential heterogenous bivalent Ancestral/Omicron BA.1 and Ancestral/Omicron BA.4/5 SARS-CoV-2 mRNA vaccines in 2022–2023 in Ontario, Canada. Immunogenicity of this unique vaccination schedule was evaluated within the COVID in Long-Term Care Study , a multisite observational cohort of long-term care and retirement home residents. Humoral and cellular immunogenicity were evaluated 7–120 days after vaccinations with first bivalent (Ancestral/Omicron BA.1; BV1) and second bivalent (Ancestral/Omicron BA.4/5; BV2) vaccines. Hybrid immunity and biological sex were considered, with measurements of anti-spike and anti-RBD (receptor binding domain) IgG and IgA antibodies by ELISA, live SARS-CoV-2 ancestral and Omicron BA.1, BA.5 and XBB.1.5 neutralizing antibodies by microneutralization assays, and T cell responses to ancestral and Omicron BA.1, BA.4/5, and XBB.1.5 spike proteins by activation-induced marker assays. Bivalent vaccination induced cross-reactive antibody and T cell responses. Higher responses were observed against ancestral SARS-CoV-2 than Omicron-specific variants, but Omicron-specific neutralizing antibodies were enhanced after bivalent vaccination compared to monovalent vaccination. Humoral responses were increased by hybrid immunity. Neutralizing antibodies against Omicron BA.1 were initially increased after BV2 compared to BV1 (especially in males), but in infection-naïve individuals there was back-boosting of ancestral neutralizing antibodies within 4 months. Enhanced CD4 + T cell responses to the ancestral spike protein were observed after BV2 compared to BV1 (particularly in females). Omicron BA.4/5 and XBB.1.5 neutralizing antibody and T cell responses were similar after BV2 and BV1. Waning of anti-SARS-CoV-2 IgG was observed after BV1 and BV2 within 4 months, and after BV1 but not BV2 for neutralizing antibodies and CD4 + T cell responses. Humoral and cellular immune responses after two heterogenous bivalent vaccines were noninferior to those after a single bivalent vaccine within four months of vaccination. Continued surveillance of vaccine immunogenicity is essential to inform evidence-based decisions on vaccination of vulnerable older adults. • Consecutive ancestral/BA.1 and ancestral/BA.4/5 bivalent mRNA vaccination. • Maintains anti-SARS-CoV-2 antibody and T cell immune responses. • Back-boosts ancestral SARS-CoV-2 antibody and T cell responses. • Enhances Omicron variant neutralizing antibodies compared to monovalent vaccination. • Produces similar Omicron-specific immunity after one and two bivalent vaccinations.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.083
Threshold uncertainty score0.165

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.032
GPT teacher head0.348
Teacher spread0.316 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations1
Published2025
Admission routes3
Has abstractyes

Explore more

Same venueVaccine→Same topicSARS-CoV-2 and COVID-19 Research→French-language works237,207→